Cargando…
Nephrotoxicity after radionuclide therapies
Radioligand therapies have opened new treatment avenues for cancer patients. They offer precise tumor targeting with a favorable efficacy-to-toxicity profile. Specifically, the kidneys, once regarded as the critical organ for radiation toxicity, also show excellent tolerance to radiation doses as hi...
Autores principales: | Parihar, Ashwin Singh, Chopra, Sejal, Prasad, Vikas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633679/ https://www.ncbi.nlm.nih.gov/pubmed/34847420 http://dx.doi.org/10.1016/j.tranon.2021.101295 |
Ejemplares similares
-
Medical management of victims contaminated with radionuclides after a “dirty bomb” attack
por: Rump, Alexis, et al.
Publicado: (2018) -
Release of patients after therapy with unsealed radionuclides
por: Commission Internationale de Protection contre les Radiations
Publicado: (2004) -
Targeted Radionuclide Therapy
por: Ersahin, Devrim, et al.
Publicado: (2011) -
Effect of Peptide Dose on Radiation Dosimetry for Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATOC: A Pilot Study
por: Prasad, Vikas, et al.
Publicado: (2021) -
EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides
por: Handkiewicz-Junak, Daria, et al.
Publicado: (2018)